Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- Pakistan
- Region
- Asia
Regulatory licences
- DMLName on licence: Glitz Pharma
Registered products
142 products
P-Zone Injection 250mg IMEach Vial ContainsCeftriaxone Sodium equivalent to Ceftriaxone 250mg(USP Specs.)250mgP-Zone Injection 500 mg IMEach Vial ContainsCeftriaxone Sodium equivalent to Ceftriaxone 500 mg (USP Specs.)500 mgP-Zone Injection 500 mg IVEach Vial ContainsCeftriaxone Sodium equivalent to Ceftriaxone 500mg(USP Specs.)500 mgPracmol 500mg TabletParacetamol 500 mg(BP Specs.)500 mgPracmol SuspensionEach 5mL Suspension Contains:Paracetamol 120mg(BP Specs.)120mg/5mLQuinglit 200mg TabletHydroxychloroquine sulfate 200mg(USP Specifications)200mgQuinine Tablet 300 mgQuinine Bisulphate 300 mg(BP Specs.)300 mgQutia 100mg TabletsQuetiapine Fumarate equivalent to Quetiapine 100 mg(USP Specifications)100 mgQutia 200mg TabletsQuetiapine Fumarate equivalent to Quetiapine 200 mg(USP Specifications)200 mgQutia 25mg TabletsQuetiapine Fumarate equivalent to Quetiapine 25 mg(USP Specifications)25 mgQutia 300mg TabletsQuetiapine Fumarate equivalent to Quetiapine 300 mg(USP Specifications)300 mgQutia 300mg XR TabletEach Estended releaes Tablet contains:Quetiapine fumarate 300mg (As per* innovator's Specifications)300mg